Phase 2CompletedAge-related condition
The Menopause After Cancer Study (MACS)
A Multimodal Technology-assisted Intervention for the Management of Menopause After Cancer: The Menopause After Cancer Study
- Sponsor
- University College Dublin (Academic or other)
- Enrollment
- 205 enrolled
- Conditions
- Menopause; Cancer; Insomnia
- Interventions
- Citalopram +/- Gabapentin + Sleepio + support person
- Ages
- adults, older adults
- Registry
- NCT04766229
Full record on ClinicalTrials.gov
From the registry
This study will recruit women with vasomotor symptoms of menopause and a prior cancer diagnosis, for whom conventional menopausal hormone therapy (MHT) is contraindicated for any reason. This study will examine if the addition of psycho-social support and digital cognitive behavioral therapy (CBT) for insomnia to standard non-hormonal pharmacotherapy can improve quality of life for these women.
Primary outcomes
- Global Quality of Life scores as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ C30) instrument
History
Last registry update
Primary completion
Started
Registered